These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38872035)

  • 1. Phase Transitions Involving Channel Hydrates of a New Pharmaceutical Compound.
    Kuang S; Shah HS; Zhao B
    Pharm Res; 2024 Jul; 41(7):1533-1541. PubMed ID: 38872035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid-state characterization and transformation of various creatine phosphate sodium hydrates.
    Xu Y; Jiang L; Huang Y; Wang JR; Mei X
    J Pharm Sci; 2014 Nov; 103(11):3688-3695. PubMed ID: 25223726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rapid approach to the preliminary assessment of the physical stability of pharmaceutical hydrates.
    Shimanovich R; Cooke M; Peterson ML
    J Pharm Sci; 2012 Oct; 101(10):4013-7. PubMed ID: 22777723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dehydration and Rehydration Mechanisms of Pharmaceutical Crystals: Classification Of Hydrates by Activation Energy.
    Takahashi M; Uekusa H
    J Pharm Sci; 2022 Mar; 111(3):618-627. PubMed ID: 34728174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid conversion of API hydrates to anhydrous forms in aqueous media.
    Petrova RI; Peresypkin A; Mortko CJ; McKeown AE; Lee J; Williams JM
    J Pharm Sci; 2009 Nov; 98(11):4111-8. PubMed ID: 19384923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dehydration of risedronate hemi-pentahydrate: analytical and physical characterization.
    Lester C; Lubey G; Dicks M; Andol G; Vaughn D; Cambron RT; Poiesz K; Redman-Furey N
    J Pharm Sci; 2006 Dec; 95(12):2631-44. PubMed ID: 16917848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in the solid state of anhydrous and hydrated forms of sodium naproxen under different grinding and environmental conditions: Evidence of the formation of new hydrated forms.
    Censi R; Rascioni R; Di Martino P
    Eur J Pharm Biopharm; 2015 May; 92():192-203. PubMed ID: 25796350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into hydrate formation and stability of morphinanes from a combination of experimental and computational approaches.
    Braun DE; Gelbrich T; Kahlenberg V; Griesser UJ
    Mol Pharm; 2014 Sep; 11(9):3145-63. PubMed ID: 25036525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of water in the physical stability of solid dosage formulations.
    Airaksinen S; Karjalainen M; Shevchenko A; Westermarck S; Leppänen E; Rantanen J; Yliruusi J
    J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding.
    Karki S; Friscić T; Jones W; Motherwell WD
    Mol Pharm; 2007; 4(3):347-54. PubMed ID: 17497885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydration Study of Piracetam Co-Crystal Hydrates.
    Liao X; Zhou N
    J Pharm Sci; 2018 Nov; 107(11):2804-2809. PubMed ID: 29969589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Solid Forms of Nitrofurantoin and 4-Aminopyridine Salt: Influence of Salt Hydration Level on Crystal Packing and Physicochemical Properties.
    Boycov DE; Drozd KV; Manin AN; Churakov AV; Perlovich GL
    Molecules; 2022 Dec; 27(24):. PubMed ID: 36558123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid-state characterization of non-stoichiometric hydrates of ester-type local anaesthetics. Part XI. Crystal polymorphism of local anaesthetic drugs.
    Schmidt AC; Schwarz I
    Int J Pharm; 2006 Aug; 320(1-2):4-13. PubMed ID: 16857329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of hydrate-screening methods.
    Cui Y; Yao E
    J Pharm Sci; 2008 Jul; 97(7):2730-44. PubMed ID: 17914731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Navigating the Waters of Unconventional Crystalline Hydrates.
    Braun DE; Koztecki LH; McMahon JA; Price SL; Reutzel-Edens SM
    Mol Pharm; 2015 Aug; 12(8):3069-88. PubMed ID: 26075319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical stability of crystal hydrates and their anhydrates in the presence of excipients.
    Salameh AK; Taylor LS
    J Pharm Sci; 2006 Feb; 95(2):446-61. PubMed ID: 16380975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thermodynamic stability considerations for isostructural dehydrates.
    Murphy BJ; Casteel MJ; Samas B; Krzyzaniak JF
    J Pharm Sci; 2012 Apr; 101(4):1486-95. PubMed ID: 22262468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the development of hydrate phases as active pharmaceutical ingredients--an example.
    Feth MP; Nagel N; Baumgartner B; Bröckelmann M; Rigal D; Otto B; Spitzenberg M; Schulz M; Becker B; Fischer F; Petzoldt C
    Eur J Pharm Sci; 2011 Jan; 42(1-2):116-29. PubMed ID: 21073949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug hydrate systems and dehydration processes studied by terahertz pulsed spectroscopy.
    Zeitler JA; Kogermann K; Rantanen J; Rades T; Taday PF; Pepper M; Aaltonen J; Strachan CJ
    Int J Pharm; 2007 Apr; 334(1-2):78-84. PubMed ID: 17129691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical properties of tamoxifen hemicitrate sesquihydrate.
    Kojima T; Katoh F; Matsuda Y; Teraoka R; Kitagawa S
    Int J Pharm; 2008 Mar; 352(1-2):146-51. PubMed ID: 18061380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.